Patient	O
management	O
may	O
need	O
to	O
be	O
altered	O
during	O
the	O
postobstructive	O
phase	O
of	O
urinary	B-Disease
tract	I-Disease
obstruction	I-Disease
.	O

Identification	O
of	O
ACP2	O
,	O
a	O
homologue	O
of	O
the	O
adenomatous	B-Disease
polyposis	I-Disease
coli	I-Disease
tumour	I-Disease
suppressor	O
.	O
